SE463716B - 2-halonicergolinderivat, foerfarande foer framstaellning av detta och en farmaceutisk beredning - Google Patents
2-halonicergolinderivat, foerfarande foer framstaellning av detta och en farmaceutisk beredningInfo
- Publication number
- SE463716B SE463716B SE8602737A SE8602737A SE463716B SE 463716 B SE463716 B SE 463716B SE 8602737 A SE8602737 A SE 8602737A SE 8602737 A SE8602737 A SE 8602737A SE 463716 B SE463716 B SE 463716B
- Authority
- SE
- Sweden
- Prior art keywords
- formula
- acid addition
- halonicergoline
- acid
- mmol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU852447A HU193782B (en) | 1985-06-21 | 1985-06-21 | Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8602737D0 SE8602737D0 (sv) | 1986-06-19 |
SE8602737L SE8602737L (sv) | 1986-12-22 |
SE463716B true SE463716B (sv) | 1991-01-14 |
Family
ID=10959403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8602737A SE463716B (sv) | 1985-06-21 | 1986-06-19 | 2-halonicergolinderivat, foerfarande foer framstaellning av detta och en farmaceutisk beredning |
Country Status (30)
Country | Link |
---|---|
US (1) | US4753949A (xx) |
JP (1) | JPS62485A (xx) |
CN (1) | CN1015365B (xx) |
AR (1) | AR241533A1 (xx) |
AT (1) | AT390614B (xx) |
AU (1) | AU594686B2 (xx) |
BE (1) | BE904957A (xx) |
CH (1) | CH671018A5 (xx) |
CS (1) | CS255875B1 (xx) |
DD (1) | DD246111A5 (xx) |
DE (1) | DE3620647A1 (xx) |
DK (1) | DK292086A (xx) |
ES (1) | ES8800953A1 (xx) |
FI (1) | FI84605C (xx) |
FR (1) | FR2583756B1 (xx) |
GB (1) | GB2176788B (xx) |
HU (1) | HU193782B (xx) |
IL (1) | IL79179A0 (xx) |
IN (1) | IN163116B (xx) |
IT (1) | IT1204865B (xx) |
LU (1) | LU86485A1 (xx) |
NL (1) | NL8601612A (xx) |
NO (1) | NO164099C (xx) |
PH (1) | PH24732A (xx) |
PL (1) | PL147390B1 (xx) |
PT (1) | PT82808B (xx) |
SE (1) | SE463716B (xx) |
SU (1) | SU1445557A3 (xx) |
YU (1) | YU107986A (xx) |
ZA (1) | ZA864633B (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU193781B (en) * | 1985-06-21 | 1987-11-30 | Richter Gedeon Vegyeszet | Process for producing 10alpha-methoxy-6-methylergoline derivatives and acid additional salts thereof |
HU196394B (en) * | 1986-06-27 | 1988-11-28 | Richter Gedeon Vegyeszet | Process for preparing 2-halogenated ergoline derivatives |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3228943A (en) * | 1962-06-11 | 1966-01-11 | Lumilysergol derivatives | |
US3879554A (en) * | 1970-03-20 | 1975-04-22 | Farmaceutici Italia | Use of 1,6-dimethyl-8-{62 -(5-bromonicotinoyloxymethyl)-10 {60 -methoxyergoline in treating cerebral and peripheral metabolic vascular disorders |
US4199579A (en) * | 1975-03-14 | 1980-04-22 | Siphar S. A. | Carbamates of 2-haloergolines and 2-haloergolenes and process for the preparation thereof |
GB1513322A (en) * | 1976-01-09 | 1978-06-07 | Farmaceutici Italia | Heterocyclic ergoline derivatives |
YU39278B (en) * | 1976-12-22 | 1984-10-31 | Lek Tovarna Farmacevtskih | Process for preparing 5-bromo nicotinic acid esters |
IT1094965B (it) * | 1978-04-05 | 1985-08-10 | Corvi Mora E | Procedimento di preparazione di derivati del lisergolo |
DE3362248D1 (en) * | 1982-04-13 | 1986-04-03 | Erba Farmitalia | Ergoline derivatives, process for producing the ergoline derivatives and pharmaceutical compositions containing them |
CH649998A5 (de) * | 1982-08-09 | 1985-06-28 | Sandoz Ag | Ergolinderivate, ein verfahren zu ihrer herstellung und heilmittel, enthaltend diese ergolinderivate als wirkstoff. |
GB8612366D0 (en) * | 1986-05-21 | 1986-06-25 | Erba Farmitalia | Ergoline esters |
GB8615471D0 (en) * | 1986-06-25 | 1986-07-30 | Erba Farmitalia | T-butyl ergoline derivatives |
-
1985
- 1985-06-21 HU HU852447A patent/HU193782B/hu not_active IP Right Cessation
-
1986
- 1986-06-10 IN IN430/CAL/86A patent/IN163116B/en unknown
- 1986-06-19 AR AR86304332A patent/AR241533A1/es active
- 1986-06-19 CH CH2487/86A patent/CH671018A5/de not_active IP Right Cessation
- 1986-06-19 SE SE8602737A patent/SE463716B/sv not_active IP Right Cessation
- 1986-06-19 FI FI862635A patent/FI84605C/fi not_active IP Right Cessation
- 1986-06-19 BE BE0/216806A patent/BE904957A/fr not_active IP Right Cessation
- 1986-06-20 ES ES556359A patent/ES8800953A1/es not_active Expired
- 1986-06-20 PT PT82808A patent/PT82808B/pt not_active IP Right Cessation
- 1986-06-20 PH PH33913A patent/PH24732A/en unknown
- 1986-06-20 DK DK292086A patent/DK292086A/da not_active Application Discontinuation
- 1986-06-20 ZA ZA864633A patent/ZA864633B/xx unknown
- 1986-06-20 SU SU864027691A patent/SU1445557A3/ru active
- 1986-06-20 IT IT20873/86A patent/IT1204865B/it active
- 1986-06-20 FR FR868608933A patent/FR2583756B1/fr not_active Expired - Fee Related
- 1986-06-20 PL PL1986260192A patent/PL147390B1/pl unknown
- 1986-06-20 JP JP61143162A patent/JPS62485A/ja active Granted
- 1986-06-20 NL NL8601612A patent/NL8601612A/nl not_active Application Discontinuation
- 1986-06-20 NO NO862493A patent/NO164099C/no unknown
- 1986-06-20 IL IL79179A patent/IL79179A0/xx not_active IP Right Cessation
- 1986-06-20 DD DD86291510A patent/DD246111A5/de not_active IP Right Cessation
- 1986-06-20 LU LU86485A patent/LU86485A1/de unknown
- 1986-06-20 AT AT0168486A patent/AT390614B/de not_active IP Right Cessation
- 1986-06-20 AU AU58916/86A patent/AU594686B2/en not_active Ceased
- 1986-06-20 YU YU01079/86A patent/YU107986A/xx unknown
- 1986-06-20 CS CS864584A patent/CS255875B1/cs unknown
- 1986-06-20 DE DE19863620647 patent/DE3620647A1/de not_active Withdrawn
- 1986-06-20 GB GB8615120A patent/GB2176788B/en not_active Expired
- 1986-06-21 CN CN86104086A patent/CN1015365B/zh not_active Expired
- 1986-06-23 US US06/877,294 patent/US4753949A/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3750596T2 (de) | 1,2,3,3a,8,8a-Hexahydro-1,3a,8-Trimethylpyrrolo[2,3-b]indole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel. | |
CA2104883A1 (fr) | Derives d'acide thienyl ou pyrrolyl carboxyliques, leur preparation et medicaments les contenant | |
EP0579681B1 (en) | Crystalline tiagabine hydrochloride monohydrate, its preparation and use | |
JP2961013B2 (ja) | 〔(アリールアルキルピペリジン−4−イル)メチル〕−2a,3,4,5−テトラヒドロ−1(2H)−アセナフチレン−1−オン類および関連化合物 | |
JP3030780B2 (ja) | 光学活性なケテンジチオアセタール誘導体及びその製造方法 | |
KR20010014316A (ko) | 8-클로로-6,11-디하이드로-11-(4-피페리딜리덴)-5H-벤조[5,6]사이클로헵타[1,2-b]피리딘의 동질이상체 | |
CZ200471A3 (cs) | Způsob purifikace N-[3-(3-kyanopyrazol[1,5-a]pyrimidin-7-yl)fenyl]-N-ethylacetamidu (zaleplon) a krystalické formy zaleplonu připravitelné tímto způsobem | |
CS270249B2 (en) | Method of purine's new derivatives production | |
RU2228931C2 (ru) | Кристаллические формы 3-(2,4-дихлорбензил)-2-метил-n-(пентилсульфонил)-3h- бензимидазол-5-карбоксамида | |
SE463716B (sv) | 2-halonicergolinderivat, foerfarande foer framstaellning av detta och en farmaceutisk beredning | |
KR100659927B1 (ko) | 다형태를갖는독사조신메실레이트의새로운형태(제iii형) | |
CA1337348C (fr) | Produits optiquement actifs de derives de 20,21-dinoreburnamenine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant | |
NO854574L (no) | Fremgangsmaate for fremstilling av en ny krystallinsk form av et benzotiazin-dioksyd-salt. | |
JPH0560478B2 (xx) | ||
US4138489A (en) | Vasodilating octahydro-1,12-methano-oxymethano[2,3-a]-indoloquinolizines | |
SE436880B (sv) | Ergol-8-en- och ergolinforeningar, sett for deras framstellning och farmaceutisk beredning | |
US7521472B2 (en) | Crystal of two-ring heterocyclic sulfonamide compound | |
US4904654A (en) | 7-chloro-5,6-dihydro-3-(5-(2-hydroxy-isopropyl)-1,2,4-oxadiazol-3-yl)-5-methyl-6-oxo-4H-imidazo[1,5a][1,4]benzodiazepine | |
EP0003286B1 (de) | Ergopeptidalkaloid-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen | |
CA2184598C (en) | Novel crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-[3-(1-methylethylamino)-2-pyridinyl]piperazine | |
KR880001280B1 (ko) | 2-할로니세르골린 유도체와 그 산부가염의 제조방법 | |
JPS5810387B2 (ja) | 4,5,6,7テトラヒドロイミダゾ〔4,5−c〕ピリジン誘導体及びその製法 | |
JPH0525170A (ja) | ピリドン誘導体、その製造法及びそれを含有する抗潰瘍剤 | |
NO152750B (no) | Fremgangsmaate for fremstilling av nitrogen brohode-kondenserte pyrimidinforbindelser | |
JP3001975B2 (ja) | 結晶性チアガビン塩酸塩−水和物、その製造方法および用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 8602737-2 Effective date: 19940110 Format of ref document f/p: F |